About Zoetis
Zoetis is a company based in Brussels (Belgium) founded in 2012.. Zoetis has completed 16 acquisitions, including Abaxis, Basepaws and Ethos Diagnostic Science. Zoetis offers products and services including Librela, Simparica TRIO, Apoquel, Solensia, and Draxxin KP. Zoetis operates in a competitive market with competitors including Ceva, PetMedix, QBiotics, Hester Biosciences and Bio-Sourcing, among others.
- Headquarter Brussels, Belgium
- Stage Public
-
Sectors
HealthcareAgriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Zoetis Services Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$15.3 M (USD), Grant
Mar 01, 2023
-
Investors
Gates Foundation
& 1 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Abaxis
& 15 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Zoetis
Zoetis is a publicly listed company on the NYSE with ticker symbol ZTS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Zoetis
Zoetis offers a comprehensive portfolio of products and services, including Librela, Simparica TRIO, Apoquel, Solensia, and Draxxin KP. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatment for canine osteoarthritis pain relief
Protection against parasites in dogs
Manages allergic skin conditions in dogs
Therapy for pain in cats
Antibiotic for cattle respiratory diseases
Unlock access to complete
Unlock access to complete
Software Development Team
282 people
Leadership Team
150 people
Senior Team
82 people
Sales and Marketing
76 people
Product Management Team
48 people
Principal Team
37 people
Operations Team
33 people
Human Resources and Administration
28 people
Unlock access to complete
Funding Insights of Zoetis
- Total Funding Total Funding
- Total Rounds 9
- Last Round Grant — $15.3M
-
First Round
First Round
(01 Apr 2015)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Grant - Zoetis | Valuation |
investors |
|
| Jan, 2023 | Amount | Grant - Zoetis | Valuation |
investors |
|
| May, 2022 | Amount | Grant - Zoetis | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Zoetis
Zoetis has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Gates Foundation and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Charitable foundation investments on poverty reduction and healthcare
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Zoetis
Zoetis has strategically engaged in corporate development activities, having acquired 16 companies. Notable acquisitions include Abaxis, Basepaws and Ethos Diagnostic Science. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Species-specific antibodies for pets are developed via a specialized platform.
|
2018 | ||||
|
Developer of monoclonal antibody therapeutics for pets
|
2017 | ||||
|
Provider of veterinary medicines, vaccines & diagnostic products supplying services
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Zoetis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zoetis Comparisons
Competitors of Zoetis
Zoetis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceva, PetMedix, QBiotics, Hester Biosciences and Bio-Sourcing, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Animal health therapeutics are developed and supplied globally by Ceva.
|
|
| domain | founded_year | HQ Location |
Developer of monoclonal antibody therapeutics for pets
|
|
| domain | founded_year | HQ Location |
Small molecules from plant extracts are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Manufacturer of animal vaccines and healthcare products
|
|
| domain | founded_year | HQ Location |
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Zoetis
Frequently Asked Questions about Zoetis
When was Zoetis founded?
Zoetis was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Where is Zoetis located?
Zoetis is headquartered in Brussels, Belgium. It is registered at Brussels, Brussels-capital Region, Belgium.
What does Zoetis do?
Zoetis was founded in 2012 and is based in Brussels, Belgium. Operations focus on the animal health sector, where medicines, vaccines, and diagnostic products are developed and distributed for livestock including poultry, swine, sheep, horses, and cattle. Solutions target disease prevention and treatment in respiratory, gastrointestinal, and reproductive systems. Additional offerings include parasiticides, anti-infectives for microbial issues, medicinal feed additives, and products for pain management and sedation.
Who are the top competitors of Zoetis?
What products or services does Zoetis offer?
Zoetis offers Librela, Simparica TRIO, Apoquel, Solensia, and Draxxin KP.
Is Zoetis publicly traded?
Yes, Zoetis is publicly traded on NYSE under the ticker symbol ZTS.
How many acquisitions has Zoetis made?
Zoetis has made 16 acquisitions, including Abaxis, Basepaws, and Ethos Diagnostic Science.
Who are Zoetis's investors?
Zoetis has 2 investors. Key investors include Gates Foundation, and European Union.
What is Zoetis's ticker symbol?
The ticker symbol of Zoetis is ZTS on NYSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.